Science Explorer Interactive view Map
Company · Osaka · Japan

Sumitomo Dainippon Pharma (Japan)

In research, Sumitomo Dainippon Pharma (Japan) stands highest in Life Sciences (#3,193 of 14,347 worldwide), Biochemistry, Genetics and Molecular Biology (#3,808 of 7,814 worldwide) and Medicine (#8,843 of 17,978 worldwide), over all time.

ds-pharma.com/index.htmlROR OpenAlex
World rank, 2022–2025
#12,802
of 28,054 · #7,751 all time
Rank in Japan
#334
of 1,070
Research works
1.8k
▼ 20% vs 2013–17
Citations
41k
22.9 per fractional work
Top-10% rate
13.3%
record average 16.5%
Open access
40%
world 28%

What is Sumitomo Dainippon Pharma (Japan) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #3,193 of 14,347 11.6%771
Biochemistry, Genetics and Molecular BiologyField #3,808 of 7,814 11.2%415
MedicineField #8,843 of 17,978 10.3%577
Health SciencesDomain #11,091 of 20,462 10.5%604
Physical SciencesDomain #12,312 of 21,541 6.2%414
NeuroscienceField #1,604 of 2,675 11.4%174
Molecular BiologySubfield #3,184 of 4,961 10.4%279
ChemistryField #2,992 of 3,369 5.1%311
Organic ChemistrySubfield #1,804 of 2,025 4.4%246

Each strip is that field’s whole ranked pool, with the notch where Sumitomo Dainippon Pharma (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.76× its world share, 11 worksBiochemistry, Geneti…Immunology and Microbiology: 5.95× its world share, 4 worksImmunology and Micro…Neuroscience: 6.62× its world share, 8 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 8.97× its world share, 2 worksPharmacology, Toxico…Chemistry: 2.57× its world share, 3 worksChemistryComputer Science: 0.02× its world share, 0 worksComputer ScienceEngineering: 0.30× its world share, 3 worksEngineeringEnvironmental Science: 0.22× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.29× its world share, 1 worksMaterials ScienceMathematics: 0.04× its world share, 0 worksMathematicsPhysics and Astronomy: 0.04× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.59× its world share, 1 worksHealth ProfessionsMedicine: 2.54× its world share, 36 worksMedicineNursing: 0.46× its world share, 0 worksNursingVeterinary: 3.58× its world share, 0 worksVeterinaryArts and Humanities: 0.08× its world share, 0 worksArts and HumanitiesEconomics, Econometrics and Finance: 0.04× its world share, 0 worksEconomics, Econometr…Psychology: 0.88× its world share, 2 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.0×. Every wedge is a field page.

Who are the top researchers at Sumitomo Dainippon Pharma (Japan)?

Ranked on the composite score, Yutaka Sekine, Junichi Matsumoto and Hiroshi Noguchi lead among researchers whose main affiliation is Sumitomo Dainippon Pharma (Japan).

  1. 1 Yutaka Sekine Japan · #122,037 worldwide 190 citations · 32 works
  2. 2 Junichi Matsumoto Japan · #247,875 worldwide 133 citations · 41 works
  3. 3 Hiroshi Noguchi Japan · #284,444 worldwide 83 citations · 41 works
  4. 4 Susumu Umemoto Japan · #411,869 worldwide 0 citations · 32 works
  5. 5 Katsuhiko Hagi Japan · #521,259 worldwide 55 citations · 21 works
  6. 6 Yoshio Katsuda Japan · #667,856 worldwide 32 citations · 16 works
  7. 7 Hitoshi Uno Japan · #673,748 worldwide 60 citations · 28 works
  8. 8 Akira Sasaki Japan · #782,532 worldwide 51 citations · 46 works
  9. 9 Masanao Shimizu Japan · #893,921 worldwide 64 citations · 44 works
  10. 10 H. Kaneko Japan · #915,333 worldwide 19 citations · 20 works
All ranked researchers at Sumitomo Dainippon Pharma (Japan)

Which keywords describe research at Sumitomo Dainippon Pharma (Japan)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Metabolic Syndrome, Inflammation, Cognitive Therapy, Antipsychotic Drugs, Neurocognitive Deficits, Depression, Neurodegeneration and Neurological Disorders.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation6▲ 3.9×27 topics
  2. Metabolic Syndrome6▲ 9.3×7 topics
  3. Oxidative Stress5▲ 3.8×16 topics
  4. Cardiovascular Disease4▲ 4.8×12 topics
  5. Depression4▲ 6.0×12 topics
  6. Antipsychotic Drugs4▲ 134×1 topic
  7. Cognitive Therapy4▲ 49×2 topics
  8. Neurocognitive Deficits4▲ 134×1 topic
  9. Neurodegeneration4▲ 16×8 topics
  10. Neurological Disorders3▲ 8.0×7 topics
  11. Clinical Guidelines3▲ 15×4 topics
  12. Genetics3▲ 6.0×7 topics
  13. Synaptic Plasticity3▲ 18×4 topics
  14. Tumor Microenvironment3▲ 8.0×5 topics
  15. Cancer Immunotherapy2▲ 21×3 topics
  16. Neuroimaging2▲ 12×5 topics
  17. Mitochondrial Dysfunction2▲ 10×5 topics
  18. Neurobiology2▲ 12×5 topics
  19. Parkinson's Disease2▲ 12×3 topics
  20. Genetic Variation2▲ 13×4 topics
  21. Immune Checkpoint Blockade2▲ 26×1 topic
  22. Immunity2▲ 7.1×4 topics
  23. PD-1 and PD-L12▲ 26×1 topic
  24. Cognitive Impairment2▲ 10×5 topics
  25. Emotion Regulation2▲ 8.6×4 topics
  26. Innate Immunity2▲ 8.5×6 topics
  27. Metabolism2▲ 5.3×9 topics
  28. Prevalence2▲ 6.5×4 topics
  29. Glycemic Control2▲ 16×3 topics
  30. Insulin Therapy2▲ 21×3 topics
  31. Treatment-Resistant Depression2▲ 40×2 topics
  32. Diagnostic Criteria2▲ 11×2 topics
  33. Neuroinflammation2▲ 8.4×4 topics
  34. Dopaminergic Neurons2▲ 35×1 topic
  35. NMDA Receptor2▲ 59×2 topics
  36. a-Synuclein2▲ 43×1 topic
  37. Cognitive Function2▲ 12×2 topics
  38. Bipolar Spectrum Disorder2▲ 90×1 topic
  39. Pluripotent Stem Cells2▲ 40×2 topics
  40. Treatment Guidelines2▲ 9.6×1 topic

Which research topics does Sumitomo Dainippon Pharma (Japan) publish most on?

By volume in 2022–2025: Schizophrenia research and treatment, Cancer Immunotherapy and Biomarkers, Parkinson's Disease Mechanisms and Treatments and Bipolar Disorder and Treatment.

Schizophrenia research a…4Schizophrenia research and treatment: 4 fractional worksCancer Immunotherapy and Biomarkers: 2 fractional worksParkinson's Disease Mechanisms and Treatments: 2 fractional worksBipolar Disorder and Treatment: 2 fractional worksImmunotherapy and Immune Responses: 1 fractional worksTreatment of Major Depression: 1 fractional worksDiabetes Treatment and M…1Diabetes Treatment and Management: 1 fractional worksNeuroscience and Neuropharmacology Research: 1 fractional worksHeart Rate Variability and Autonomic Control: 1 fractional worksAnalytical Chemistry and…1Analytical Chemistry and Chromatography: 1 fractional works
Psychiatry and Mental healthOncologyNeurologyImmunology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Schizophrenia research and treatment Psychiatry and Mental health 4 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 2 works
  3. 3 Parkinson's Disease Mechanisms and Treatments Neurology 2 works
  4. 4 Bipolar Disorder and Treatment Psychiatry and Mental health 2 works
  5. 5 Immunotherapy and Immune Responses Immunology 1 works
  6. 6 Treatment of Major Depression Pharmacology 1 works
  7. 7 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
  8. 8 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 1 works
  9. 9 Heart Rate Variability and Autonomic Control Cardiology and Cardiovascular Medicine 1 works
  10. 10 Analytical Chemistry and Chromatography Spectroscopy 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.7%not open60.3%

World: 28% of research is openly available.

with international co-authors11.9%domestic only88.1%

World: 19% is written across borders.

How has Sumitomo Dainippon Pharma (Japan)'s research output changed?

Output in 2018–2022 was 20% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Osaka

All research institutions in Osaka

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.